Identification and characterization of a functional mitochondrial angiotensin system

The renin-angiotensin (Ang) system regulates multiple physiological functions through Ang II type 1 and type 2 receptors. Prior studies suggest an intracellular pool of Ang II that may be released in an autocrine manner upon stretch to activate surface membrane Ang receptors. Alternatively, an intracellular renin-Ang system has been proposed, with a primary focus on nuclear Ang receptors. A mitochondrial Ang system has not been previously described. Here we report that functional Ang II type 2 receptors are present on mitochondrial inner membranes and are colocalized with endogenous Ang. We demonstrate that activation of the mitochondrial Ang system is coupled to mitochondrial nitric oxide production and can modulate respiration. In addition, we present evidence of age-related changes in mitochondrial Ang receptor expression, i.e., increased mitochondrial Ang II type 1 receptor and decreased type 2 receptor density that is reversed by chronic treatment with the Ang II type 1 receptor blocker losartan. The presence of a functional Ang system in human mitochondria provides a foundation for understanding the interaction between mitochondria and chronic disease states and reveals potential therapeutic targets for optimizing mitochondrial function and decreasing chronic disease burden with aging.

[1]  T. Hussain,et al.  Role of the angiotensin II AT2 receptor in inflammation and oxidative stress: opposing effects in lean and obese Zucker rats. , 2011, American journal of physiology. Renal physiology.

[2]  B. Ratliff,et al.  Angiotensin II Regulates NOS Expression in Afferent Arterioles of the Developing Porcine Kidney , 2010, Pediatric Research.

[3]  B. Ratliff,et al.  Angiotensin II regulates NOS expression in afferent arterioles of the developing porcine kidney. , 2010, Pediatric research.

[4]  David G. Nicholls,et al.  Bioenergetic analysis of isolated cerebrocortical nerve terminals on a microgram scale: spare respiratory capacity and stochastic mitochondrial failure , 2009, Journal of neurochemistry.

[5]  G. Remuzzi,et al.  Disruption of the Ang II type 1 receptor promotes longevity in mice. , 2009, The Journal of clinical investigation.

[6]  H. Shaltout,et al.  Nuclear angiotensin II type 2 (AT2) receptors are functionally linked to nitric oxide production. , 2009, American journal of physiology. Renal physiology.

[7]  L. Blatter,et al.  Characteristics and function of cardiac mitochondrial nitric oxide synthase , 2009, The Journal of physiology.

[8]  B. Roques,et al.  Conversion of Renal Angiotensin II to Angiotensin III Is Critical for AT2 Receptor-Mediated Natriuresis In Rats , 2008, Hypertension.

[9]  P. Brookes,et al.  Mitochondria as a target for the cardioprotective effects of nitric oxide in ischemia-reperfusion injury. , 2008, Antioxidants & redox signaling.

[10]  P. Wardman,et al.  Fluorescent and luminescent probes for measurement of oxidative and nitrosative species in cells and tissues: progress, pitfalls, and prospects. , 2007, Free radical biology & medicine.

[11]  A. Boveris,et al.  Mitochondrial nitric oxide synthase, a voltage-dependent enzyme, is responsible for nitric oxide diffusion to cytosol. , 2007, Frontiers in bioscience : a journal and virtual library.

[12]  B. Piotrkowski,et al.  Renal mitochondrial dysfunction in spontaneously hypertensive rats is attenuated by losartan but not by amlodipine. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[13]  C. Szabó,et al.  Mitochondrial NO and reactive nitrogen species production: does mtNOS exist? , 2006, Nitric oxide : biology and chemistry.

[14]  Steven P Jones,et al.  The ubiquitous role of nitric oxide in cardioprotection. , 2006, Journal of molecular and cellular cardiology.

[15]  A. Duarte,et al.  Valsartan improves mitochondrial function in hearts submitted to acute ischemia. , 2005, European journal of pharmacology.

[16]  S. Jois,et al.  Transport of angiotensin peptides across the Caco-2 monolayer , 2004, Peptides.

[17]  J. Yager,et al.  Mitochondrial localization of ER and ER in human MCF7 cells , 2004 .

[18]  A. Boveris,et al.  Heart mitochondrial nitric oxide synthase. Effects of hypoxia and aging. , 2004, Molecular aspects of medicine.

[19]  G. Mazzocchi,et al.  Investigations on the turnover of adrenocortical mitochondria , 1975, Cell and Tissue Research.

[20]  R. Carey,et al.  Angiotensin AT2 Receptors Directly Stimulate Renal Nitric Oxide in Bradykinin B2-Receptor–Null Mice , 2003, Hypertension.

[21]  R. Jensen,et al.  Protein import into and across the mitochondrial inner membrane: role of the TIM23 and TIM22 translocons. , 2002, Biochimica et biophysica acta.

[22]  P. Cavadini,et al.  Protein import and processing reconstituted with isolated rat liver mitochondria and recombinant mitochondrial processing peptidase. , 2002, Methods.

[23]  J. Poderoso,et al.  Modulation of liver mitochondrial NOS is implicated in thyroid-dependent regulation of O(2) uptake. , 2001, American journal of physiology. Heart and circulatory physiology.

[24]  J. Cook,et al.  In Vitro Evidence for an Intracellular Site of Angiotensin Action , 2001, Circulation research.

[25]  H. Lother,et al.  The Angiotensin II AT2 Receptor Is an AT1Receptor Antagonist* , 2001, The Journal of Biological Chemistry.

[26]  C. Llorens-Cortes,et al.  Angiotensin III: a central regulator of vasopressin release and blood pressure , 2001, Trends in Endocrinology & Metabolism.

[27]  T. Oyama,et al.  Activity and responsiveness of the renin-angiotensin system in the aging rat. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[28]  R. Latini,et al.  Up-Regulation of AT1 and AT2 Receptors in Postinfarcted Hypertrophied Myocytes and Stretch-Mediated Apoptotic Cell Death , 2000 .

[29]  R. Carey,et al.  Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats. , 2000, Hypertension.

[30]  R. Carey,et al.  Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R C Scaduto,et al.  Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives. , 1999, Biophysical journal.

[32]  Q. Li,et al.  Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. , 1998, The Journal of clinical investigation.

[33]  C. Richter,et al.  Nitric oxide synthase activity in mitochondria , 1997, FEBS letters.

[34]  O. Feron,et al.  Nitric oxide synthases: which, where, how, and why? , 1997, Journal of Clinical Investigation.

[35]  S. Anderson.  Ageing and the renin-angiotensin system. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[36]  F. Luft,et al.  Effects of intracellular angiotensin II in vascular smooth muscle cells. , 1996, Circulation research.

[37]  V. Cachofeiro,et al.  Nitric oxide and the depressor response to angiotensin blockade in hypertension. , 1996, Hypertension.

[38]  G. Burnstock,et al.  Immunocytochemical evidence for a mitochondrially located nitric oxide synthase in brain and liver. , 1995, Biochemical and biophysical research communications.

[39]  C. Cooper,et al.  Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase , 1994, FEBS letters.

[40]  J. Sadoshima,et al.  Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro , 1993, Cell.

[41]  H. Heitsch,et al.  The possible role of angiotensin II subtype AT2 receptors in endothelial cells and isolated ischemic rat hearts , 1993, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[42]  C. Baylis,et al.  Proximal tubular metalloprotease activity is decreased in the senescent rat kidney. , 1992, Life sciences.

[43]  W. Neupert,et al.  The carboxyl-terminal two-thirds of the ADP/ATP carrier polypeptide contains sufficient information to direct translocation into mitochondria. , 1987, The Journal of biological chemistry.

[44]  D. Gautheron,et al.  Purification of pig heart mitochondrial membranes. Enzymatic and morphological characterization as compared to microsomes. , 1974, Biochimica et biophysica acta.

[45]  K. Catt,et al.  Angiotensin II receptors in bovine adrenal cortex. Modification of angiotensin II binding by guanyl nucleotides. , 1974, The Journal of biological chemistry.

[46]  Albert Bauk.  Angiotensin II Receptors in Bovine Adrenal Cortex , 1974 .

[47]  T. Goodfriend,et al.  Biochemical Effects of Angiotensin , 1974 .

[48]  P. Dempsey,et al.  Inotropic Agents in Hypoxic Cat Myocardium: DEPRESSION AND POTENTIATION , 1972, Circulation research.

[49]  K. Kent,et al.  Clinical and Conceptual Uses of Angiotensin Receptors , 1972 .

[50]  P. Khairallah,et al.  Angiotensin II: Rapid Localization in Nuclei of Smooth and Cardiac Muscle , 1971, Science.